Liao Xin, Li Ying-Jie, Tan Jin-Lan, Zhang Miao, Zhong Fa-Zhan, Wang Chang-Xi, Qiu Jiang, Fu Qian, Liu Long-Shan, Gao Yan
Department of Nephrology, Guangzhou Women and Children's Medical Center, Guangzhou 510120, China.
Zhongguo Dang Dai Er Ke Za Zhi. 2020 Jul;22(7):755-761. doi: 10.7499/j.issn.1008-8830.2003308.
To study the clinical features of catch-up growth of body height after kidney transplantation in children and related influencing factors.
A retrospective analysis was performed from the chart review data of 15 children who underwent kidney transplantation in Guangzhou Women and Children's Medical Center from July 2017 to November 2019. According to whether the increase in height standard deviation score (ΔHtSDS) in the first year after kidney transplantation reached ≥0.5, the children were divided into a catch-up group with 8 children and a non-catch-up group with 7 children. According to whether final HtSDS was ≥-2, the children were divided into a standard group with 6 children and a non-standard group with 9 children. The features of catch-up growth of body height and related influencing factors were compared between groups.
The data showed that median ΔHtSDS was 0.8 in the first year after transplantation, which suggested catch-up growth of body height. There was a significant difference in HtSDS between the non-catch-up and catch-up groups (P<0.05). Baseline HtSDS before transplantation was positively correlated with HtSDS at the end of follow-up (r=0.622, P<0.05) and was negatively correlated with ∆HtSDS in the first year after transplantation (r=-0.705, P<0.05). Age of transplantation and mean dose of glucocorticoid (GC) per kg body weight were risk factors for catch-up growth after kidney transplantation (OR=1.23 and 1.74 respectively; P<0.05), while baseline HtSDS and use of antihypertensive drugs were independent protective factors for catch-up growth (OR=0.08 and 0.18 respectively; P<0.05); baseline HtSDS and ΔHtSDS in the first year after kidney transplantation were influencing factors for final HtSDS (β=0.984 and 1.271 respectively; P<0.05).
Kidney transplantation should be performed for children as early as possible, growth retardation before transplantation should be improved as far as possible, and multiple treatment methods (including the use of GC and antihypertensive drugs) should be optimized after surgery, in order to help these children achieve an ideal body height.
研究儿童肾移植后身高追赶生长的临床特征及相关影响因素。
回顾性分析2017年7月至2019年11月在广州市妇女儿童医疗中心接受肾移植的15例儿童的病历资料。根据肾移植后第1年身高标准差得分(ΔHtSDS)的增加是否达到≥0.5,将患儿分为追赶组8例和非追赶组7例。根据最终身高标准差得分(HtSDS)是否≥ -2,将患儿分为达标组6例和未达标组9例。比较各组身高追赶生长的特征及相关影响因素。
数据显示移植后第1年ΔHtSDS中位数为0.8,提示有身高追赶生长。非追赶组与追赶组的HtSDS有显著差异(P<0.05)。移植前基线HtSDS与随访结束时的HtSDS呈正相关(r = 0.622,P<0.05),与移植后第1年的ΔHtSDS呈负相关(r = -0.705,P<0.05)。移植年龄和每千克体重糖皮质激素(GC)的平均剂量是肾移植后追赶生长的危险因素(OR分别为1.23和1.74;P<0.05),而基线HtSDS和使用降压药物是追赶生长的独立保护因素(OR分别为0.08和0.18;P<0.05);基线HtSDS和肾移植后第1年的ΔHtSDS是最终HtSDS的影响因素(β分别为0.984和1.271;P<0.05)。
儿童肾移植应尽早进行,移植前应尽可能改善生长迟缓情况,术后应优化多种治疗方法(包括使用GC和降压药物),以帮助这些儿童达到理想身高。